2031년까지 글로벌 및 카타르 암 치료제 시장 전망

Global & Qatar Cancer Therapeutics Market to 2031

상품코드Portugal Cancer Therapeutics Market.pdf
발행기관Business Market Insights
발행일2025.05.26
페이지 수100 Pages
포맷PDF
커버리지Country

₩3,600,000 – ₩6,600,000

보고서 요약(국문)

GLOBOCAN 2022에 따르면 카타르에서는 2022년에 약 1,733건의 새로운 암 환자가 발생했습니다. 유방암이 14.3%로 가장 흔했으며, 대장암이 10.5%, 전립선암이 6.4%로 그 뒤를 이었습니다. 암 진단 건수 증가로 인해 면역요법 및 표적 치료를 포함한 첨단 치료법에 대한 관심이 높아지고 있습니다.

카타르 정부는 국가 비전 2030을 통해 의료 시스템을 강화하고 의학 연구를 지원하는 것을 최우선 과제로 삼고 있습니다. 카타르 암 협회와 하마드 의료공사(HMC)와 같은 기관들은 암 인식 제고 및 환자 치료에 중요한 역할을 하고 있습니다. HMC 산하 국립 암 치료 및 연구 센터(NCCCR)는 화학요법, 방사선 치료, 임상 시험 등 최첨단 치료를 제공하는 선도적인 시설입니다. 카타르 암 계획 2023-2026은 2026년까지 달성해야 할 전략적 목표를 제시하며, 완화적 가정 간호 확대와 암 치료의 정밀 의학 발전에 중점을 두고 있습니다. 이러한 계획과 증가하는 암 발병률에 힘입어 카타르의 암 치료제 시장은 꾸준히 성장할 것으로 예상됩니다.

보고서 요약(영어 원문)

According to GLOBOCAN 2022, Qatar reported approximately 1,733 new cancer cases in 2022. Breast cancer was the most common, accounting for 14.3% of cases, followed by colorectal cancer at 10.5% and prostate cancer at 6.4%. The increasing number of cancer diagnoses has led to greater emphasis on advanced treatment options, including immunotherapy and targeted therapies.

Healthcare is a priority for Qatar’s government under its National Vision 2030, which aims to enhance the healthcare system and support medical research. Organizations such as the Qatar Cancer Society and Hamad Medical Corporation (HMC) play vital roles in cancer awareness and patient care. HMC’s National Center for Cancer Care and Research (NCCCR) is a leading facility providing state-of-the-art treatments like chemotherapy, radiotherapy, and clinical trials. The Qatar Cancer Plan 2023–2026 outlines strategic goals to be achieved by 2026, focusing on expanding palliative homecare and advancing precision medicine in cancer treatment. Supported by these initiatives and the rising cancer burden, Qatar’s cancer therapeutics market is projected to grow steadily.

상세 목차

TABLE OF CONTENTS

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation:

4. Qatar Cancer Therapeutics Market Landscape

4.1 Overview

4.2 Ecosystem Analysis

4.2.1 List of Vendors in the Value Chain

5. Cancer Therapeutics Market Key Market Dynamics

5.1 Cancer Therapeutics Market – Key Market Dynamics

5.2 Market Drivers

5.3 Market Restraints

5.4 Market Opportunities

5.5 Future Trends

5.6 Impact of Drivers and Restraints

6. Qatar Cancer Therapeutics Market – Analysis

6.1 Qatar Cancer Therapeutics Market Revenue (US$ Million), 2021–2031

6.2 Qatar Cancer Therapeutics Market Revenue and Forecast Analysis

7. Qatar Cancer Therapeutics Market Analysis – by Therapy Types

7.1 Qatar Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types

8. Qatar Cancer Therapeutics Market Analysis – by Indications

8.1 Qatar Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

9. Qatar Cancer Therapeutics Market Analysis – by Distribution Channel

9.1 Qatar Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players

10.1 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.2 Partnerships and Collaborations

11.2 Other Developments

12. Company Profiles

12.1 Bristol-Myers Squibb Co

12.1. 1 Key Facts

12.1. 2 Business Description

12.1. 3 Products and Services

12.1. 4 Financial Overview

12.1. 5 SWOT Analysis

12.1. 6 Key Developments

12.2 AbbVie Inc

12.2. 1 Key Facts

12.2. 2 Business Description

12.2. 3 Products and Services

12.2. 4 Financial Overview

12.2. 5 SWOT Analysis

12.2. 6 Key Developments

12.3 Johnson & Johnson

12.3. 1 Key Facts

12.3. 2 Business Description

12.3. 3 Products and Services

12.3. 4 Financial Overview

12.3. 5 SWOT Analysis

12.3. 6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4. 1 Key Facts

12.4. 2 Business Description

12.4. 3 Products and Services

12.4. 4 Financial Overview

12.4. 5 SWOT Analysis

12.4. 6 Key Developments

12.5 Pfizer Inc

12.5. 1 Key Facts

12.5. 2 Business Description

12.5. 3 Products and Services

12.5. 4 Financial Overview

12.5. 5 SWOT Analysis

12.5. 6 Key Developments

12.6 AstraZeneca Plc

12.6. 1 Key Facts

12.6. 2 Business Description

12.6. 3 Products and Services

12.6. 4 Financial Overview

12.6. 5 SWOT Analysis

12.6. 6 Key Developments

12.7 Merck KGaA

12.7. 1 Key Facts

12.7. 2 Business Description

12.7. 3 Products and Services

12.7. 4 Financial Overview

12.7. 5 SWOT Analysis

12.7. 6 Key Developments

12.8 Novartis AG

12.8. 1 Key Facts

12.8. 2 Business Description

12.8. 3 Products and Services

12.8. 4 Financial Overview

12.8. 5 SWOT Analysis

12.8. 6 Key Developments

12.9 Astellas Pharma Inc

12.9. 1 Key Facts

12.9. 2 Business Description

12.9. 3 Products and Services

12.9. 4 Financial Overview

12.9. 5 SWOT Analysis

12.9. 6 Key Developments

12.10 Eli Lilly and Co

12.10. 1 Key Facts

12.10. 2 Business Description

12.10. 3 Products and Services

12.10. 4 Financial Overview

12.10. 5 SWOT Analysis

12.10. 6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

언급된 주요 기업들

TABLE OF COMPANIES

1. Bristol-Myers Squibb Co

2. AbbVie Inc

3. Johnson & Johnson

4. F. Hoffmann-La Roche Ltd

5. Pfizer Inc

6. AstraZeneca Plc

7. Merck KGaA

8. Novartis AG

9. Astellas Pharma Inc

10. Eli Lilly and Co

표 목록 (Tables)

TABLE OF TABLES

Table 1. Qatar Cancer Therapeutics Market Segmentation

Table 2. List of Vendors

Table 3. Qatar Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)

Table 4. Qatar Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 5. Qatar Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types

Table 6. Qatar Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types

Table 7. Qatar Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 8. Qatar Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 9. Qatar Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 10. Qatar Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 11. List of Abbreviations

그림 목록 (Figures)

TABLE OF FIGURES

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. Qatar Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031

Figure 3. Heat Map Analysis by Key Players

Figure 4. Company Positioning and Concentration